LONDON – The pharmaceutical industry exhaled sharply and prepared to labor over the fine print in 1,246 pages of text after the EU and U.K. announced they had agreed a post-Brexit trade deal on Christmas Eve. The EU/U.K. Trade and Cooperation Agreement means the risk of a crash-out Brexit on Dec. 31 is over, and there will be no tariffs or quotas on the import and export of goods.